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Abstract
Objective: To identify risk factors associated with neonatal intermediate or intensive care unit 
(NICU) stay ≥ 3 days among women with threatened late preterm birth (PTB).
Study design: Secondary analysis of women with nonanomalous, singleton gestations enrolled 
in multicenter trial of betamethasone versus placebo for late PTB. Maternal and obstetric 
characteristics at time of presentation with threatened PTB were compared between those with and 
without NICU stay ≥3 days. Multivariable logistic regression identified risk factors for NICU stay 
≥ 3 days.
Result: Of 2795 eligible mother-neonate dyads, 962 (34%) had NICU stay ≥3 days. Gestational 
age and fetal growth restriction as the reason for threatened PTB had the strongest association with 
NICU stay ≥3 days in the final model (AUC 0.76).
Conclusion: Maternal and obstetric characteristics at the time of admission for threatened late 
PTB should be considered when counseling patients about the probability of NICU stay ≥3 days.
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Late preterm birth, defined as delivery between 34 weeks 0 days and 36 weeks 6 days, 
accounts for the majority of all preterm births [1] and the majority of all neonatal intensive 
care unit admissions [2]. While late preterm neonates have a shorter length of stay in the 
neonatal intensive care unit than those delivered preterm at earlier gestational ages, they still 
make up the largest proportion of all neonatal intensive care unit admissions because of the 
overall incidence of late preterm birth. As such, the staff and resources required to care for 
late preterm neonates contribute significantly to the total neonatal intensive care unit costs in 
the USA [3].
Women who present with threatened late preterm birth are counseled about the increased 
risk for short term neonatal morbidities such as respiratory distress, hyperbilirubinemia, 
hypothermia, hypoglycemia and feeding problems [4,5], as well as the increased chance of 
admission to the neonatal intensive care unit for treatment of these conditions [6]. However, 
there is considerable variability in the proportion of late preterm neonates admitted to the 
neonatal intensive care unit (ranging from 20% to 50%) [5,7–10], which makes counseling 
difficult. This variability may be due to differences in institution-specific practices or other 
high-risk maternal and obstetric characteristics among the populations studied.
While previous studies have evaluated the maternal and obstetric characteristics associated 
with late preterm neonatal intensive care unit admission [7,11], many have included factors 
not known at the time of initial presentation (i.e. birthweight and route of delivery), and 
none have studied factors associated with prolonged neonatal intensive care unit admission. 
Previous studies also have not considered the potential impact of antenatal betamethasone in 
threatened late preterm birth, which was shown in a placebo-controlled randomized clinical 
trial [6] to reduce neonatal respiratory complications and neonatal intensive care unit stay ≥3 
days. Thus, our objective was to evaluate risk factors associated with neonatal intensive care 
unit stay ≥3 days among neonates born to women who present with threatened late preterm 
birth. We hypothesized that both maternal demographic factors and baseline obstetric 
characteristics would be associated with neonatal intensive care unit stay ≥3 days, and that 
gestational age would be the most important risk factor.
Materials and methods
This is a secondary analysis of the Antenatal Late Preterm Steroids (ALPS) trial conducted 
by the Eunice Kennedy Shriver National Institute of Child Health and Human Development 
(NICHD) Maternal-Fetal Medicine Units (MFMU) Network. The ALPS trial was a 
randomized, placebo-controlled trial conducted at 17 university-based medical centers 
participating in the MFMU Network from October 2010 to February 2015. Detailed methods 
are published [6]. Briefly, Institutional Review Board (IRB) approval and written, informed 
consent was obtained from study participants. Eligible women with a singleton gestation and 
threatened late preterm delivery were enrolled between 34 weeks 0 days and 36 week 5 days 
and randomized to receive a 48-h course of intramuscular betamethasone or placebo. With 
the exception of study drug allocation, all obstetric management, including decisions 
regarding timing of delivery and neonatal intensive care unit admission, was at the discretion 
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of the primary provider. The findings of the main trial showed that compared to placebo, 
antenatal betamethasone reduced respiratory morbidity at birth (14.4% vs. 11.6%; relative 
risk 0.80, 95% CI0.66–0.97). There was no significant difference in neonatal intermediate or 
intensive care unit admission (44.9% vs. 41.8%), however, antenatal betamethasone did 
significantly reduce neonatal intermediate or intensive care unit stay ≥3 days (37.0% vs. 
32.9%; relative risk 0.89, 95% CI 0.80–0.98) [6].
For this secondary analysis, women were excluded if they delivered a fetus with a major 
anomaly. Our primary outcome was neonatal intermediate or intensive care unit stay ≥3 
days, which for the remainder of this manuscript we will refer to as neonatal intensive care 
unit stay ≥3 days. We evaluated baseline characteristics available at time of initial 
presentation with threatened late preterm birth, including maternal age, body mass index 
(BMI), race, ethnicity, in vitro fertilization (IVF), private insurance, tobacco use during 
pregnancy, gestational diabetes mellitus, chronic hypertension, gestational hypertension or 
preeclampsia, abnormal placentation (placenta previa or accreta), placental abruption, 
antepartum bleeding, nonreassuring fetal heart rate tracing, gestational age at presentation, 
reason for threatened preterm birth, neonatal sex, and any betamethasone receipt. Planned 
route of delivery could not be included due to the amount of missing data (49%). These 
characteristics were compared in the bivariable analysis by neonatal intensive care unit stay 
≥3 days using chi-square, Mann–Whitney U, and Student’s t-test, as appropriate.
Multivariable logistic regression modeling was used to estimate odds ratios (OR) for the 
association between risk factors and neonatal intensive care unit admission ≥3 days. All 
maternal demographic characteristics and obstetric characteristics, known at the time of 
admission, were considered in the initial models. Multiple degree-of-freedom likelihood 
ratio tests were used to reduce any nonsignificant predictors from the model using the 
statistical significance of p < .10. A receiver operating characteristic (ROC) curve was 
generated, and the area under the curve (AUC) was calculated for the final logistic 
regression model. A calculator to estimate the probability of neonatal intensive care unit stay 
≥3 days was developed based on a linear combination of beta coefficients for each risk factor 
in the final regression model (www.mom-baby.org/alps-nicu).
Analyses were performed with Stata, Version 14.0 (StataCorp, College Station, TX). 
Institutional Review Board (IRB) approval and written, informed consent was obtained for 
the original trial at all participating institutions. The current analysis was conducted using 
de-identified databases and was approved by the IRB at the University of North Carolina, 
Chapel Hill.
Results
Of the 2831 mother-neonate dyads randomized in the main trial, 2795 (99%) met inclusion 
criteria for this secondary analysis. Of these, 1196 (43%) neonates were admitted to a 
neonatal intensive care unit and 962 (34%) neonates had a neonatal intensive care unit stay 
≥3 days. Overall, the mean gestational age at initial presentation with threatened late preterm 
delivery was 35.5 ± 0.8 weeks and the mean gestational age at delivery was 36.1 ± 1.1 
weeks. The most common reasons for threatened late preterm birth were preterm labor 
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(28%), preterm prelabor rupture of membranes (22%), and preeclampsia (26%). More than 
two-thirds of neonates were delivered vaginally (69%).
Neonates admitted to the neonatal intensive care unit for ≥3 days (compared to those not 
admitted to the neonatal intensive care unit or admitted to the neonatal intensive care unit for 
<3 days) differed by maternal demographic and obstetric characteristics known at the time of 
initial presentation (Table 1). Gestational age at presentation, the reason for threatened late 
preterm birth, hypertensive disorder of pregnancy, nonreassuring fetal status, and abnormal 
placentation were associated with neonatal intensive care unit stay ≥3 days in the final 
regression model (Table 2). For each additional week of gestational age at presentation, there 
was a 70% reduction in the odds of neonatal intensive care unit stay ≥3 days. Preterm 
prelabor rupture of membranes, preeclampsia, fetal growth restriction, oligohydramnios, and 
other maternal or fetal reasons for threatened late preterm birth were associated with higher 
odds (1.7-fold to9.7-fold) of neonatal intensive care unit stay ≥3 days, compared to preterm 
labor. Severe hypertensive disorder of pregnancy, abnormal placentation and nonreassuring 
fetal status were also associated with higher odds of neonatal intensive care unit stay ≥3 
days. These maternal and obstetric characteristics used to estimate neonatal intensive care 
unit stay ≥3 days had an AUC of 0.76.
Among all of the maternal and obstetric characteristics associated with neonatal intensive 
care unit stay ≥3 days, gestational age at presentation and fetal growth restriction as the 
indication for threatened late preterm birth had the greatest magnitude of association. The 
estimated probability of neonatal intensive care unit stay ≥3 days decreased across 
advancing gestational age, adjusted for other covariates in the final regression model (Figure 
1). While the probability of neonatal intensive care unit stay ≥3 days was almost 80% for 
women who presented at 34 weeks’ gestation, this decreased to ~15% at the end of the 36th 
week. Using the final multivariable logistic regression model, the estimated probability of 
neonatal intensive care unit stay ≥3 days was significantly higher if the indication for 
threatened late preterm birth was fetal growth restriction, compared to preterm labor (36% 
vs. 32%). Maternal demographic and obstetric characteristics for individual patients who 
present with threatened late preterm birth can be entered into a calculator derived from this 
models (www.mombaby.org/alps-nicu) to estimate the probability of neonatal intensive care 
unit stay ≥3 days. For example, a medically uncomplicated woman who presents at 36 5/7 
weeks’ gestation with preterm labor who receives antenatal betamethasone has a 4% 
probability of delivering a neonate who will require neonatal intensive care unit stay ≥3 
days. In contrast, a woman who presents at 34 2/7 weeks’ gestation with fetal growth 
restriction, nonreassuring status, preeclampsia with severe features and who does not receive 
antenatal betamethasone has a 97% probability of delivering a neonate who will require 
neonatal intensive care unit stay ≥3 days.
Discussion
In this secondary analysis, we found several maternal demographic and obstetric 
characteristics known at the time of initial presentation with threatened late preterm birth 
that were associated with neonatal intensive care unit stay ≥3 days. Gestational age at 
presentation had the largest magnitude of association among all risk factors. Baseline 
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characteristics can be used to estimate the probability of neonatal intensive care unit stay ≥3 
days after presentation with threatened late preterm birth.
The overall frequency of neonatal intensive care unit admission observed in our study (43%) 
is similar to previous reports (ranging from 20% to 50%) [5, 7–10], suggesting that this is an 
appropriate cohort to identify risk factors that would be generalizable to other obstetric 
populations. We observed that the most important risk factor was gestational age and that the 
probability of neonatal intensive care unit stay ≥3 days dropped rapidly with advancing 
gestational age. As such, it is possible that the reported variation in neonatal intensive care 
unit admission may be explained by differences in gestational age of previously studied 
populations or differences in individual hospital practices.
We identified risk factors for late preterm neonatal intensive care unit stay ≥3 days that are 
similar to those shown previously for neonatal intensive care unit admission: gestational age, 
fetal weight, and premature rupture of membranes as a reason for threatened late preterm 
birth. These three factors, along with antepartum hemorrhage, medical disorders during 
pregnancy, and mode of delivery have previously been used to develop a risk score to predict 
neonatal intensive care unit admission [8]. The cut-off score that produced the highest AUC 
in this prior study was ≥1, however, sensitivity and specificity were only modest at ~75%, 
and the PPV was low at 45%. The authors found the NPV may be more clinically useful at 
93% for pregnancies with a score of <1. However, this risk score included delivery factors, 
which are not known at the time of initial presentation and counseling [8]. Furthermore, 
<10% of the women studied to develop this risk score received antenatal corticosteroids, 
which is known to improve late preterm neonatal respiratory outcomes and reduce neonatal 
intensive care unit stay ≥3 days.
Our study has several strengths. We had a large study population with almost 3000 neonates 
and information on demographic and obstetric characteristics known at the time of 
presentation with threatened late preterm birth collected rigorously by trained research staff. 
The results are generalizable to US women who present with threatened late preterm birth as 
subjects were enrolled at 17 different university-based clinical centers across different 
geographic regions in the USA with diverse racial and ethnic backgrounds. Our study, 
however, is not without limitations. Although we considered many factors associated with 
the outcomes of interest, there may be other variables, such as institution-specific practices 
and neonatal intensive care unit admission policies [12], that were not measured. Clinical 
practices may differ at rural and community hospitals such that the results of this study are 
not generalizable. We also have not yet validated this calculator, but plan to do so once we 
have access to another large database of women with threatened late preterm birth who 
received antenatal corticosteroids. Lastly, we were unable to evaluate the specific indication 
for neonatal intensive care unit stay ≥3 days or the exact duration of intensive care unit stay 
as these were not included in the available database.
Nonetheless, our results demonstrate that there are several demographic and obstetric risk 
factors associated with neonatal intensive care unit stay ≥3 days. These factors, especially 
gestational age, should be considered when counseling women at risk for late preterm birth. 
They may also be helpful in planning the location of delivery if the probability of prolonged 
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neonatal intensive care unit admission is high. Facilitating a maternal transfer prior to 
delivery among those pregnancies at highest risk for prolonged neonatal intensive care unit 
admission could help minimize maternal-infant separation and improve skin-to-skin care, 
breastfeeding rates, and maternal-infant bonding. In addition to the maternal and neonatal 
clinical benefits of determining who is at the highest risk for prolonged neonatal intensive 
care unit admission, this information could also be utilized from a healthcare management 
perspective in order to optimize the allocation of neonatal intensive care unit beds among 
different hospitals.
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Probability of neonatal intensive care unit stay ≥3 days by gestational age at time of 
presentation with threatened late preterm birth Footnote: Probability of neonatal intensive 
care unit stay ≥3 days and 95% CI estimated from the final multivariable logistic regression 
model (adjusted for gestational age at presentation, reason for threatened late preterm birth, 
betamethasone receipt, hypertensive disorder of pregnancy, abnormal placentation, and 
nonreassuring fetal status) and graphed across increasing gestational age at presentation.
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